{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:51:56Z","timestamp":1792900316270,"version":"4.5.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la recherche sur le cancer","doi-asserted-by":"publisher","award":["ARCMOB2023010006185"],"award-info":[{"award-number":["ARCMOB2023010006185"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Lung cancer screening programs concern smokers at risk for cardiovascular diseases (CVDs) and chronic obstructive pulmonary disease (COPD). The LUMASCAN (LUng Cancer Screening, MArkers and low-dose computed tomography SCANner) study aimed to evaluate the acceptability and feasibility of screening for these 3 diseases in a community population with centralized organization and to determine low-dose computed tomography (CT) markers associated with each disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This cohort enrolled participants meeting National Comprehensive Cancer Network criteria (v1.2014) in an organized lung cancer\u2013screening program including low-dose CT scans; spirometry; evaluations of coronary artery calcifications (CACs); and a smoking cessation plan at inclusion, 1, and 2 years; then telephone follow-up. Outcomes were the participation rate and the proportion of participants affected by lung cancer, obstructive lung disease, or CVD events. Logistic-regression models were used to identify radiological factors associated with each disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Between 2016 and 2019, a total of 302 participants were enrolled: 61% men; median age 58.8\u2009years; 77% active smoker; 11% diabetes; 38% hypertension; and 27% taking lipid-lowering agents. Inclusion, 1-year, and 2-year participation rates were 99%, 81%, 79%, respectively. After a median follow-up of 5.81\u2009years, screenings detected 12 (4%) lung cancer, 9 of 12 via low-dose CT (78% localized) and 3 of 12 during follow-up (all stage IV), 83 (27%) unknown obstructive lung disease, and 131 (43.4%) moderate to severe CACs warranting a cardiology consultation. Preexisting COPD and moderate to severe CACs were associated with major CVD events with odds ratios of 1.98 (95% confident interval [CI] = 1.00 to 3.88) and 3.27 (95% CI = 1.72 to 6.43), respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The LUMASCAN study demonstrated the feasibility of combined screening for lung cancer, COPD, and CVD in a community population. Its centralized organization enabled high participation and coordination of healthcare practitioners.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jncics\/pkae082","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T01:59:49Z","timestamp":1726279189000},"source":"Crossref","is-referenced-by-count":14,"title":["Beyond lung cancer screening, an opportunity for early detection of chronic obstructive pulmonary disease and cardiovascular diseases"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-0804","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Gendarme","sequence":"first","affiliation":[{"name":"Pulmonology Department, Centre Hospitalier Intercommunal de Cr\u00e9teil , Cr\u00e9teil,","place":["France"]},{"name":"Inserm U955, IMRB, Universit\u00e9 Paris-Est Cr\u00e9teil , Cr\u00e9teil,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Maitre","sequence":"additional","affiliation":[{"name":"Pulmonology Department, Centre Hospitalier Intercommunal de Cr\u00e9teil , Cr\u00e9teil,","place":["France"]},{"name":"Inserm U955, IMRB, Universit\u00e9 Paris-Est Cr\u00e9teil , Cr\u00e9teil,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Hanash","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center , Houston, TX,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Pairon","sequence":"additional","affiliation":[{"name":"Inserm U955, IMRB, Universit\u00e9 Paris-Est Cr\u00e9teil , Cr\u00e9teil,","place":["France"]},{"name":"Occupational Medicine Department, Centre Hospitalier Intercommunal de Cr\u00e9teil , Cr\u00e9teil,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Canoui-Poitrine","sequence":"additional","affiliation":[{"name":"Inserm U955, IMRB, Universit\u00e9 Paris-Est Cr\u00e9teil , Cr\u00e9teil,","place":["France"]},{"name":"Public Health Department, Henri-Mondor Hospital , Cr\u00e9teil,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Choua\u00efd","sequence":"additional","affiliation":[{"name":"Pulmonology Department, Centre Hospitalier Intercommunal de Cr\u00e9teil , Cr\u00e9teil,","place":["France"]},{"name":"Inserm U955, IMRB, Universit\u00e9 Paris-Est Cr\u00e9teil , Cr\u00e9teil,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"8","key":"2024101417395009200_pkae082-B1","doi-asserted-by":"publisher","first-page":"CD013829","DOI":"10.1002\/14651858.CD013829.pub2","article-title":"Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality","volume":"8","author":"Bonney","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"23","key":"2024101417395009200_pkae082-B2","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1200\/JClinOncol.20.02574","article-title":"Benefits and harms of lung cancer screening by chest computed tomography: a systematic review and meta-analysis","volume":"39","author":"Passiglia","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"2024101417395009200_pkae082-B3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/thoraxjnl-2018-212547","article-title":"Second round results from the Manchester \u201cLung Health Check\u201d community-based targeted lung cancer screening pilot","volume":"74","author":"Crosbie","year":"2019","journal-title":"Thorax"},{"issue":"5","key":"2024101417395009200_pkae082-B4","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/S1470-2045(23)00104-3","article-title":"Defining the road map to a UK national lung cancer screening programme","volume":"24","author":"O\u2019Dowd","year":"2023","journal-title":"Lancet Oncol"},{"key":"2024101417395009200_pkae082-B5","volume-title":"Interactive Map of Lung Cancer Screening","author":"The Lung Cancer Policy Network","year":"2022","edition":"1st ed."},{"issue":"12","key":"2024101417395009200_pkae082-B6","doi-asserted-by":"publisher","first-page":"e067263","DOI":"10.1136\/bmjopen-2022-067263","article-title":"Lung CAncer SCreening in French women using low-dose CT and Artificial intelligence for DEtection: the CASCADE study protocol","volume":"12","author":"Revel","year":"2022","journal-title":"BMJ Open"},{"issue":"12","key":"2024101417395009200_pkae082-B7","doi-asserted-by":"publisher","first-page":"e067191","DOI":"10.1136\/bmjopen-2022-067191","article-title":"Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol","volume":"12","author":"Boulate","year":"2022","journal-title":"BMJ Open"},{"issue":"3","key":"2024101417395009200_pkae082-B8","doi-asserted-by":"publisher","first-page":"e025026","DOI":"10.1136\/bmjopen-2018-025026","article-title":"LUCSO-1-French pilot study of LUng Cancer Screening with low-dose computed tomography in a smokers population exposed to Occupational lung carcinogens: study protocol","volume":"9","author":"Delva","year":"2019","journal-title":"BMJ Open"},{"key":"2024101417395009200_pkae082-B9","author":"4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening"},{"issue":"5","key":"2024101417395009200_pkae082-B10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"2024101417395009200_pkae082-B11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"2024101417395009200_pkae082-B12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.21037\/tlcr-20-746","article-title":"Added benefits of early detection of other diseases on low-dose CT screening","volume":"10","author":"Yip","year":"2021","journal-title":"Transl Lung Cancer Res"},{"issue":"34","key":"2024101417395009200_pkae082-B13","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"2024101417395009200_pkae082-B14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01613-2021","article-title":"Scan-based competing death risk model for reevaluating lung cancer computed tomography screening eligibility","volume":"59","author":"Schreuder","year":"2021","journal-title":"Eur Respir J"},{"key":"2024101417395009200_pkae082-B15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fonc.2017.00308","article-title":"Influencing cancer screening participation rates-providing a combined cancer screening program (a \u201cone stop\u201d shop) could be a potential answer","volume":"7","author":"Bobridge","year":"2017","journal-title":"Front Oncol"},{"issue":"5","key":"2024101417395009200_pkae082-B16","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s00330-021-08422-7","article-title":"Can we increase efficiency of CT lung cancer screening by combining with CVD and COPD screening? Results of an early economic evaluation","volume":"32","author":"Behr","year":"2022","journal-title":"Eur Radiol"},{"issue":"1","key":"2024101417395009200_pkae082-B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10654-019-00519-0","article-title":"Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: Rationale and design of the ImaLife (Imaging in Lifelines) Study","volume":"35","author":"Xia","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"2024101417395009200_pkae082-B18","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1007\/s00330-023-10474-w","article-title":"Willingness to participate in combination screening for lung cancer, chronic obstructive pulmonary disease and cardiovascular disease in four European countries","volume":"34","author":"Behr","year":"2023","journal-title":"Eur Radiol"},{"issue":"3","key":"2024101417395009200_pkae082-B19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/14017431.2015.1039572","article-title":"Coronary artery calcification detected in lung cancer screening predicts cardiovascular death","volume":"49","author":"Rasmussen","year":"2015","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"2024101417395009200_pkae082-B20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1148\/radiol.15142062","article-title":"Association of coronary artery calcification and mortality in the national lung screening trial: a comparison of three scoring methods","volume":"276","author":"Chiles","year":"2015","journal-title":"Radiology"},{"issue":"5","key":"2024101417395009200_pkae082-B21","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.chest.2020.12.004","article-title":"Quantitative emphysema on low-dose CT imaging of the chest and risk of lung cancer and airflow obstruction: an analysis of the national lung screening trial","volume":"159","author":"Labaki","year":"2021","journal-title":"Chest"},{"issue":"5","key":"2024101417395009200_pkae082-B22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1513\/AnnalsATS.201811-817RL","article-title":"The prevalence of obstructive lung disease in a lung cancer screening cohort: analysis of the national lung screening trial-American college of radiology image network cohort","volume":"16","author":"de-Torres","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"2024101417395009200_pkae082-B23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12890-022-02263-w","article-title":"Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context","volume":"22","author":"Quinn-Scoggins","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"3","key":"2024101417395009200_pkae082-B24","doi-asserted-by":"publisher","first-page":"2003386","DOI":"10.1183\/13993003.03386-2020","article-title":"Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening","volume":"58","author":"Schreuder","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"2024101417395009200_pkae082-B25","doi-asserted-by":"publisher","first-page":"2300533","DOI":"10.1183\/13993003.00533-2023","article-title":"ERS\/ESTS\/ESTRO\/ESR\/ESTI\/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer","volume":"62","author":"O\u2019Dowd","year":"2023","journal-title":"Eur Respir J"},{"issue":"5","key":"2024101417395009200_pkae082-B26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/RTI.0000000000000097","article-title":"ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4)","volume":"29","author":"Kazerooni","year":"2014","journal-title":"J Thorac Imaging"},{"issue":"5","key":"2024101417395009200_pkae082-B27","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.21037\/jtd.2018.04.76","article-title":"Qualitative coronary artery calcium assessment on CT lung screening exam helps predict first cardiac events","volume":"10","author":"Malcolm","year":"2018","journal-title":"J Thorac Dis"},{"key":"2024101417395009200_pkae082-B28","doi-asserted-by":"publisher","first-page":"106245","DOI":"10.1016\/j.rmed.2020.106245","article-title":"Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study","volume":"176","author":"Gazourian","year":"2021","journal-title":"Respir Med"},{"issue":"2","key":"2024101417395009200_pkae082-B29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"3","key":"2024101417395009200_pkae082-B30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00214-2017","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary","volume":"49","author":"Vogelmeier","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"2024101417395009200_pkae082-B31","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.chest.2021.09.002","article-title":"Guideline-recommended lung cancer screening adherence is superior with a centralized approach","volume":"161","author":"Smith","year":"2022","journal-title":"Chest"},{"issue":"1","key":"2024101417395009200_pkae082-B32","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.cllc.2021.09.009","article-title":"Results of second round lung cancer screening by low-dose CT scan\u2014French Cohort Study (DEP-KP80)","volume":"23","author":"Leleu","year":"2022","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"2024101417395009200_pkae082-B33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.chest.2022.01.054","article-title":"Patient perspectives on longitudinal adherence to lung cancer screening","volume":"162","author":"Holman","year":"2022","journal-title":"Chest"},{"issue":"2","key":"2024101417395009200_pkae082-B34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cllc.2019.10.014","article-title":"Lung cancer screening by low-dose CT scan: baseline results of a french prospective study","volume":"21","author":"Leleu","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"2024101417395009200_pkae082-B35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jtho.2020.09.024","article-title":"Contribution of a blood-based protein biomarker panel to the classification of indeterminate pulmonary nodules","volume":"16","author":"Ostrin","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"6","key":"2024101417395009200_pkae082-B36","doi-asserted-by":"publisher","first-page":"2200795","DOI":"10.1183\/13993003.00795-2022","article-title":"Detection of COPD in the SUMMIT study lung cancer screening cohort using symptoms and spirometry","volume":"60","author":"Tisi","year":"2022","journal-title":"Eur Respir J"},{"issue":"7","key":"2024101417395009200_pkae082-B37","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1513\/AnnalsATS.201911-857OC","article-title":"Prevalence, symptom burden, and underdiagnosis of chronic obstructive pulmonary disease in a lung cancer screening cohort","volume":"17","author":"Ruparel","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"2024101417395009200_pkae082-B38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/thoraxjnl-2019-213584","article-title":"Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD","volume":"75","author":"Balata","year":"2020","journal-title":"Thorax"},{"issue":"9","key":"2024101417395009200_pkae082-B39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1164\/rccm.201505-0894OC","article-title":"Airflow limitation and histology shift in the national lung screening trial. The NLST-ACRIN cohort substudy","volume":"192","author":"Young","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101417395009200_pkae082-B40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.lungcan.2018.08.006","article-title":"Targeted lung cancer screening selects individuals at high risk of cardiovascular disease","volume":"124","author":"Balata","year":"2018","journal-title":"Lung Cancer"},{"key":"2024101417395009200_pkae082-B41","doi-asserted-by":"publisher","first-page":"110040","DOI":"10.1016\/j.ejrad.2021.110040","article-title":"Moderate-severe coronary calcification predicts long-term cardiovascular death in CT lung cancer screening: the ITALUNG trial","volume":"145","author":"Mascalchi","year":"2021","journal-title":"Eur J Radiol"},{"issue":"12","key":"2024101417395009200_pkae082-B42","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1136\/thoraxjnl-2018-212812","article-title":"Evaluation of cardiovascular risk in a lung cancer screening cohort","volume":"74","author":"Ruparel","year":"2019","journal-title":"Thorax"},{"issue":"14","key":"2024101417395009200_pkae082-B43","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"key":"2024101417395009200_pkae082-B44","doi-asserted-by":"publisher","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"25","key":"2024101417395009200_pkae082-B45","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"SCORE2 Working Group and ESC Cardiovascular Risk Collaboration","year":"2021","journal-title":"European Heart Journal"},{"issue":"16","key":"2024101417395009200_pkae082-B46","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"issue":"11","key":"2024101417395009200_pkae082-B47","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/ehjci\/jeaa168","article-title":"Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial","volume":"21","author":"van der Aalst","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024101417395009200_pkae082-B48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.lungcan.2020.12.031","article-title":"Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?","volume":"153","author":"Durham","year":"2021","journal-title":"Lung Cancer"},{"issue":"7","key":"2024101417395009200_pkae082-B49","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/thx.2009.133751","article-title":"Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial","volume":"65","author":"van der Aalst","year":"2010","journal-title":"Thorax"},{"issue":"6","key":"2024101417395009200_pkae082-B50","doi-asserted-by":"publisher","first-page":"dju084","DOI":"10.1093\/jnci\/dju084","article-title":"Impact of lung cancer screening results on smoking cessation","volume":"106","author":"Tammem\u00e4gi","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2024101417395009200_pkae082-B51","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jtho.2020.02.008","article-title":"Potential impact of cessation interventions at the point of lung cancer screening on lung cancer and overall mortality in the United States","volume":"15","author":"Cao","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"8","key":"2024101417395009200_pkae082-B52","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/jnci\/djab002","article-title":"Cost-effectiveness of smoking cessation interventions in the lung cancer screening setting: a simulation study","volume":"113","author":"Cadham","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2024101417395009200_pkae082-B53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.chest.2022.06.048","article-title":"Immediate, remote smoking cessation intervention in participants undergoing a targeted lung health check: quit smoking lung health intervention trial, a randomized controlled trial","volume":"163","author":"Williams","year":"2023","journal-title":"Chest"},{"issue":"2","key":"2024101417395009200_pkae082-B54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1164\/rccm.201705-0909CI","article-title":"Lung cancer screening and smoking cessation clinical trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) collaboration","volume":"197","author":"Joseph","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["JNCI Cancer Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jncics\/advance-article-pdf\/doi\/10.1093\/jncics\/pkae082\/59107304\/pkae082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/8\/5\/pkae082\/59748216\/pkae082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jncics\/article-pdf\/8\/5\/pkae082\/59748216\/pkae082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T17:40:02Z","timestamp":1728927602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jncics\/article\/doi\/10.1093\/jncics\/pkae082\/7756408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jncics\/pkae082","relation":{},"ISSN":["2515-5091"],"issn-type":[{"value":"2515-5091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,9,2]]},"article-number":"pkae082"}}